Celebrex and HO Study
Condition(s):Heterotopic OssificationLast Updated:December 15, 2022Enrolling by invitation
Hide Studies Not Open or Pending
Condition(s):Heterotopic OssificationLast Updated:December 15, 2022Enrolling by invitation
Condition(s):InflammationLast Updated:February 23, 2017Terminated
Condition(s):Breast CarcinomaLast Updated:November 15, 2019Withdrawn
Condition(s):Pain, PostoperativeLast Updated:February 7, 2024Completed
Condition(s):Major Depressive Disorder; NeuroinflammationLast Updated:November 22, 2023Recruiting
Condition(s):Endometrium CancerLast Updated:January 10, 2020Unknown status
Condition(s):Breast Neoplasms; Breast CancerLast Updated:January 9, 2018Completed
Condition(s):Breast CancerLast Updated:June 23, 2020Completed
Condition(s):HealthyLast Updated:May 30, 2017Completed
Condition(s):Pharmacokinetics of Celecoxib in ChildrenLast Updated:February 8, 2024Recruiting
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.